Format

Send to

Choose Destination
Nat Biomed Eng. 2018 May;2(5):293-303. doi: 10.1038/s41551-018-0229-7. Epub 2018 Apr 23.

Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells.

Author information

1
College of Physicians and Surgeons, Columbia University, New York, NY 10032.
2
Department of Medicine, Columbia University, New York, NY 10032.
3
Department of Biomedical Engineering, Columbia University, New York, NY 10027.
4
Department of Pathology and Cell Biology, Columbia University, New York, NY 10032.
5
Department of Systems Biology, Columbia University, New York, NY 10032.
6
Department of Biochemistry & Molecular Biophysics, Columbia University, New York, NY 10032.

Abstract

The ability of extracellular vesicles (EVs) to regulate a broad range of cellular processes has recently been exploited for the treatment of diseases. For example, EVs secreted by stem cells injected into infarcted hearts can induce recovery through the delivery of stem-cell-specific miRNAs. However, the retention of the EVs and the therapeutic effects are short-lived. Here, we show that an engineered hydrogel patch capable of slowly releasing EVs secreted from cardiomyocytes derived from induced pluripotent stem (iPS) cells reduced arrhythmic burden, promoted ejection-fraction recovery, decreased cardiomyocyte apoptosis 24 hours after infarction, and reduced infarct size and cell hypertrophy 4 weeks post-infarction when implanted onto infarcted rat hearts. We also show that the EVs are enriched with cardiac-specific miRNAs known to modulate cardiomyocyte-specific processes. The extended delivery of EVs secreted from iPS-cell-derived cardiomyocytes into the heart may help understand heart recovery and treat heart injury.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center